CClinicalTrials.gg
Status unknownNCT03786874IMPACTTUpdated Dec 26, 2018

"Impact of a Programme to Improve Interaction Among Professionals on the Management of Task Interruptions"

An interventional study of Identify work interruptions and Understand work interruptions in Quality of Life, sponsored by Nantes University Hospital. Status unknown at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-12-26.

Sponsored by Nantes University Hospital · Not applicable, Interventional, and Other

The sponsor has not verified this record recently (last verified Dec 2018), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

In 2017, all IMPACTT investigators experimented in coordinated manner on multifacet intervention program, proposed by the present research protocol, with 2 teams from healthcare units from the PDL region. This experiment followed collaborative work aiming to raise team awareness on task interruptions. Given the existing data in the literature, the investigators hypothesise that the implementation of a multifacet program focusing on interactions within a team could enable the percentage of task interruptions linked to interactions between coordination functions and healthcare provision activities to be decreased by 33%. This decrease would concern task interruptions that are avoidable, in order to improve healthcare safety and teamwork.

Also, the main objective of this project is to measure the impact of a program on the evolution of the characteristics of avoidable task interruptions. The project combines quantitative data (observations, questionnaire) and qualitative data (interviews).

Read the detailed description

This research is a controlled, randomised, blind, pragmatic intervention study (36 months). From the list of volunteering teams meeting inclusion criteria, a random selection will be made. This will enable the formation of two groups of 20 teams each (control group and experimental group). An observational method coupled with a validated questionnaire transfer will allow teams to be questioned about their avoidable task interruptions (control group and experimental group).

The multifacet intervention program is based the concept of teamwork implementation. Targeting potential for improvement will be decided and implemented by each team (experimental group).

Statistics analysis will be conducted on teams before and after the implementation of the program. The assessment criteria will be: the evolution of characteristics of the task interruptions observed (interactions between coordination functions and care delivery functions, prevalence, avoidability, duration, resumption of tasks, social representations of task interruptions).

02

Conditions studied

  • Quality of Life

Keywords

  • Risk management
  • health & safety
  • task interruptions
  • teamwork
03

In context

Lead sponsor

Nantes University Hospital is the lead sponsor of 825 studies on the registry; 195 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • volunteering healthcare teams from healthcare centres in the PDL region,
  • public and private legal statuses;
  • with at least one activity in standard medical and/or surgical hospitalisation unit,
  • agreeing to take part in the project,
  • formalising their commitment to the multifacet program (see section 4),
  • including 50 professionals at the most,
  • including at least the following professional categories: medical, paramedical, administrative, managerial and medical-technical/psycho-social.

Exclusion criteria

Exclusion Criteria:

  • Healthcare teams who do not belong to a healthcare unit in the PDL region
  • Healthcare teams who do not work in a medical and/or surgical hospitalisation unit.
  • Paediatric healthcare teams
  • Teams that have already been subjected to a methodological support program from one of the co-investigating units on how to manage task interruptions,
  • Teams that do not meet the criteria for commitment to the multifacet program
  • Teams of more than 50 members
  • Teams who do not include the following professional categories: medical, paramedical, administrative, managerial, medical-technical/psycho-social.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Active comparator
    20 teams the first year (G1)

    control group

    Other: Identify work interruptions · Other: Understand work interruptions

  • Experimental
    20 teams second year (G2)

    case group with implementation of the multi-unit team accompaniment intervention.

    Other: Identify work interruptions · Other: Understand work interruptions · Other: Act to limited work interruptions

Interventions

  • OtherIdentify work interruptions

    estimate baseline characteristics of the collaborative working model (proportion expressed as a percentage)

  • OtherUnderstand work interruptions

    Team-review of the results of the task interruption and professional representations, identify activities to protect from task interruption

  • OtherAct to limited work interruptions

    Adaptation of organizations; Awareness raising and Coaching for change

06

What researchers measure

Primary outcomes

  1. proportion of avoidable task interruptions

    Results from Dual Perspectives Method (DPM)

    Time frame: 1 year

  2. sources and frequencies of task interruptions

    Results from Auto-administered questionnaire (TAA-KH-S)

    Time frame: 1 year

Secondary outcomes

  1. prevalence of task interruptions

    Time measurement of the duration of task interruption upon restart of work

    Time frame: 1 year

07

Study locations

1 site
  • CHU de Nantes
    Nantes, France
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 26, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03786874
Lead sponsor
Nantes University Hospital
Responsible party
Sponsor
First posted
Dec 26, 2018
Start date
Jan 1, 2019 (estimated)
Primary completion
Jan 1, 2021 (estimated)
Completion
Jan 1, 2022 (estimated)
Last update
Dec 26, 2018

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion